Medication
Meropenem for Injection Usp and Sodium Chloride Injection Usp
DIN 02544334 · B. Braun Medical Inc Likely a generic
What it is
- Active ingredients
- Meropenem — 500 mg
- Form and route
- Powder For Solution · Intravenous
- Schedule
- PRESCRIPTION
- Authorised since
- 2025-03-25
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
- Meropenem for Injection
- Meropenem for Injection, Usp
- Taro-Meropenem
- Meropenem for Injection
- Meropenem for Injection
- Meropenem for Injection
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
How it is classified
- Anatomical main group
- Anti-infectives for systemic use
- ATC code
- J01DH02
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of J01DH02, see the WHO ATC/DDD Index.
Recalls and safety alerts
Recall matching is not available yet.
RxMonitor does not yet match Health Canada recalls to individual products — that arrives in a later release. Nothing on this page should be read as confirming that this medication has not been recalled.
Search Health Canada recalls for Meropenem for Injection Usp and Sodium Chloride Injection Usp →